Wearable nasal technology

Rhinomed is a global medical device company enhancing respiration, sleep, diagnosis of upper respiratory disease and nasal drug delivery.

Find out more

Introducing RHINOSWAB

A more comfortable nasal swab for COVID-19 and upper respiratory pathogens including influenza and RSV.

Find out more about RHINOSWAB

And RHINOSWAB JUNIOR

The happy way to swab children.

Find out more about RHINOSWAB JUNIOR

Rhinomed
knows noses

Rhinomed is a wearable nasal technology company that seeks to radically improve the way you breathe, sleep, maintain your health, diagnose disease and take medication.

We create medical devices that are used by millions of people globally.

With a pipeline of compelling innovation focused on clear unmet clinical needs, we invite you to experience firsthand the difference Rhinomed can make to your way of life.

Respiratory Sample collection

Rhinoswab standardizes the sample collection process for respiratory viruses like covid-19, flu and RSV, making it safe, reliable and comfortable for clinicians and patients alike.

Sleep & Snoring

About half of the population snore. Mute dilates the nasal passages making nasal breathing easier, reducing mouth breathing and helping you to breathe more, snore less and sleep better.

Breathing & Sport

Breathing clearly and easily is a key element in aerobic activity. Turbine is designed to assist athletes to overcome nasal obstruction and congestion by increasing airflow by up to 38%.

Clinical programs

Rhinomed’s wearable nasal technology supports a wide range of applications from stenting to diagnosis and nasal drug delivery.

News

Rhinomed launches fully underwritten rights issueJuly 24, 2024
Rhinomed today announces a fully underwritten non-renounceable rights issue of fully paid ordinary shares, to raise approximately A$3.54 million. The funds raised will be used to drive growth in Rhinomed’s … Read more
European Launch of Revolutionary New Swab for Testing Children for Respiratory DiseasesNovember 16, 2022
The world’s most child-friendly respiratory swab was launched in Europe today at Medica 2022 in Dusseldorf, Germany. Rhinoswab Junior is the first nasal swab developed specifically for children. Its unique design … Read more
New study says there is a better swab for testing children for covid and other virusesOctober 18, 2022
A new study suggests the traditional swab suffers from strong reluctance for use for children and a new Melbourne-designed Rhinoswab Junior is the preferred method of sample collection. The reluctance … Read more
Study confirms new nasal swab is most accurate, comfortable and easy for kidsSeptember 26, 2022
Rhinomed is pleased to advise of the forthcoming publication of a further study and data by researchers from the Murdoch Children’s Research Institute and the Royal Children’s Hospital (RCH) Melbourne confirming the … Read more
Surescreen Australia & Rhinomed – Rhinoswab Supply DealJuly 18, 2022
Rhinomed Limited is pleased to report that it has finalised an exclusive supply agreement with SureScreen Australia to supply Rhinoswabs and Rhinoswab Juniors for inclusion in SureScreen’s class-leading range of … Read more
Victorian Government orders RhinoswabSeptember 10, 2021
Rhinomed has received an initial purchase order for one million Rhinoswabs from the Victorian Department of Health (DH) to support Victoria’s testing capability. This follows the recent NSW Health Pathology … Read more

See all news articles